Eli Lilly and Company (LLY) announced that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1. In addition, the company announced that Karen Walker will transition her role with Lilly, resigning as a member of Lilly’s board of directors effective Dec. 31. In 2025, Walker will collaborate with Lilly on certain digital commercial activities. Moeller is the chairman of the board, president and CEO of Procter & Gamble (PG).
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly Canada ‘disappointed’ by CDA-AMC’s Final Recommendation for Ebglyss
- Lilly’s muvalaplin lowered lipoprotein(a) levels in adults in Phase 2 trial
- Eli Lilly sues to change hospital drug discount payments, WSJ reports
- Eli Lilly and Co (NYSE:LLY) Sues Federal Health Agency over Hospital Drug Discounts
- Wolfe sees attractive Eli Lilly opportunity on price drop, starts at Outperform